おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Auxilium Pharmaceuticals
company
About
Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $43M
- Industries
- Biotechnology,Health Care,Market Research,Pharmaceutical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$43M
Auxilium Pharmaceuticals has raised a total of
$43M
in funding over 2 rounds. Their latest funding was raised on
Nov 7, 2003 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 7, 2003 | Series D | $43M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Auxilium Pharmaceuticals is funded by 1 investors.
Perseus-Soros Biopharmaceutical Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Perseus-Soros Biopharmaceutical Fund
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
